Loading…

PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRα through the IGF-I-mediated signaling pathway

Highlights ► In the present study, we first found that PAPP-A inhibits ABCA1, ABCG1, SR-BI expression and reduces cholesterol efflux in THP-1 macrophage-derived foam cells. ► LXRα is involved in PAPP-A-induced down-regulation of ABCA1, ABCG1 and SR-BI in cells. ► PAPP-A promotes the IGF-1/PI3-K/Akt...

Full description

Saved in:
Bibliographic Details
Published in:Atherosclerosis 2012-06, Vol.222 (2), p.344-354
Main Authors: Tang, Shi-Lin, Chen, Wu-Jun, Yin, Kai, Zhao, Guo-Jun, Mo, Zhong-Cheng, Lv, Yun-Cheng, Ouyang, Xin-Ping, Yu, Xiao-Hua, Kuang, Huai-Jun, Jiang, Zhi-Sheng, Fu, Yu-Chang, Tang, Chao-Ke
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights ► In the present study, we first found that PAPP-A inhibits ABCA1, ABCG1, SR-BI expression and reduces cholesterol efflux in THP-1 macrophage-derived foam cells. ► LXRα is involved in PAPP-A-induced down-regulation of ABCA1, ABCG1 and SR-BI in cells. ► PAPP-A promotes the IGF-1/PI3-K/Akt signaling pathway in cells. ► The IGF-1/PI3-K/Akt signaling pathway may be related to down-regulated expression of LXRα, ABCA1, ABCG1 and SR-BI by PAPP-A in THP-1 macrophage-derived foam cells.
ISSN:0021-9150
1879-1484
DOI:10.1016/j.atherosclerosis.2012.03.005